Novel treatment
AssigneeBeecham-Wuelfing GmbH & Co. KG
InventorsDieter Angersbach, Charles D. Nicholson, Joachim Goring, Brian Morgan, Jonathan R. S. Arch
Life of this patent
Estimating the term…
Abstract
A method for the treatment of cerebral vascular and neuronal degenerative disorders associated with learning, memory and cognitive dysfunctions including cerebral senility, multi-infarct dementia and senile dementia of the Alzheimer type and/or peripheral vascular disease and/or proliferative skin disease in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof.
Claims2
A method for the treatment of cerebral vascular and neuronal degenerative disorders related to learning, memory and cognitive dysfunctions in mammals including humans, which comprises administering to the mammal in need of such treatment an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.